Granhall, Charlotte
Bækdal, Tine A.
Breitschaft, Astrid
Søndergaard, Flemming L.
Anderson, Thomas W.
Thomsen, Mette
Clinical trials referenced in this document:
Documents that mention this clinical trial
Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration
https://doi.org/10.1007/s13300-021-01106-x
Funding for this research was provided by:
Novo Nordisk A/S
Article History
Received: 19 February 2021
Accepted: 23 June 2021
First Online: 28 July 2021